DCGI: Itolizumab approved for restricted emergency use in COVID-19
The Drugs Controller General of India has approved Itolizumab, the medicine used to cure psoriasis for “restricted emergency use” againat the treatment of COVID-19 patients with moderate to severe acute…
Premas Biotech SARS-Cov-2 Vaccine Candidate moves for Animal Trials
Gurgaon: Gurgaon-based Premas Biotech, which developed the world’s first triple antigen virus-like particle (VLP) vaccine candidate for SARS CoV-2 virus, announces that it has progressed into animal trials. At the…
Generic version of remdesivir at Rs 4,000 per vial launched by CIPLA
Cipla, Pharma Giant on Wednesday has announced that it has launched its generic version of antiviral drug remdesivir at Rs 4,000 per vial, which is among the lowest globally, and…
‘Coronavirus Over?’ Face masks, hand sanitisers no more essential items by the Government
Consumer Affairs Secretary Leena Nandan said that has said that Face masks and hand sanitisers are no more essential products as their supply is sufficient in the country and, therefore,…
Rajasthan pharma seeks support from Government to set up API parks
The Rajasthan Pharmaceutical Manufacturers Association (RPMA) met Rohit Kumar Singh, State’s Additional Chief Secretary – Health and sought support to set up API pharma parks/pharma clusters in the State for…
Gujarat FDCA: Test license issued to Hetero for manufacturing lyophilized injection of remdesivir
Test license has been issued by the Gujarat Food and Drug Control Administration (FDCA) to Hyderabad-based Hetero Labs for facilitating manufacturing of lyophilized injection of remdesivir, the drug meant for…
NPPA directs manufacturers and importers to submit MRP of pulse oximeter and oxygen concentrator
The National Pharmaceutical Pricing Authority (NPPA) has directed all the manufacturers and importers of pulse oximeter and oxygen concentrator to submit maximum retail price (MRP) of for monitoring the price…
Bharat Biotech’s COVAXIN gets DCGI approval for Phase I & II Human Clinical Trials
COVAXIN has been successfully developed by Bharat Biotech, a vaccine for COVID-19 by collaborating with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV). The SARS-CoV-2…
20,000 vials of Remdesivir to be supplied by Hetero across India
Hetero Healthcare is ready to deliver the first set of 20,000 vials in two equal lots of 10,000 each. One lot will be immediately supplied to Hyderabad, Delhi, Gujarat, Tamil…
Maha FDA: PPE manufacturers directed to test & certify PPE kits in Mumbai-based labs
The Maharashtra Food and Drug Administration (FDA) has directed the PPE manufacturers to test and certify PPE kits in Mumbai-based labs as per Union health ministry guidelines. The Maha FDA…
